177 related articles for article (PubMed ID: 17050546)
21. DNA structure-dependent recruitment of telomeric proteins to single-stranded/double-stranded DNA junctions.
Yanez GH; Khan SJ; Locovei AM; Pedroso IM; Fletcher TM
Biochem Biophys Res Commun; 2005 Mar; 328(1):49-56. PubMed ID: 15670749
[TBL] [Abstract][Full Text] [Related]
22. POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end.
Hockemeyer D; Sfeir AJ; Shay JW; Wright WE; de Lange T
EMBO J; 2005 Jul; 24(14):2667-78. PubMed ID: 15973431
[TBL] [Abstract][Full Text] [Related]
23. LIM-domain proteins TRIP6 and LPP associate with shelterin to mediate telomere protection.
Sheppard SA; Loayza D
Aging (Albany NY); 2010 Jul; 2(7):432-44. PubMed ID: 20634563
[TBL] [Abstract][Full Text] [Related]
24. Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cells.
Binz N; Shalaby T; Rivera P; Shin-ya K; Grotzer MA
Eur J Cancer; 2005 Dec; 41(18):2873-81. PubMed ID: 16253503
[TBL] [Abstract][Full Text] [Related]
25. Insights into POT1 structural dynamics revealed by cryo-EM.
Smith EW; Lattmann S; Liu ZB; Ahsan B; Rhodes D
PLoS One; 2022; 17(2):e0264073. PubMed ID: 35176105
[TBL] [Abstract][Full Text] [Related]
26. POT1 proteins in green algae and land plants: DNA-binding properties and evidence of co-evolution with telomeric DNA.
Shakirov EV; Song X; Joseph JA; Shippen DE
Nucleic Acids Res; 2009 Dec; 37(22):7455-67. PubMed ID: 19783822
[TBL] [Abstract][Full Text] [Related]
27. Human POT1 facilitates telomere elongation by telomerase.
Colgin LM; Baran K; Baumann P; Cech TR; Reddel RR
Curr Biol; 2003 May; 13(11):942-6. PubMed ID: 12781132
[TBL] [Abstract][Full Text] [Related]
28. Telomerase inhibition and cell growth arrest after telomestatin treatment in multiple myeloma.
Shammas MA; Shmookler Reis RJ; Li C; Koley H; Hurley LH; Anderson KC; Munshi NC
Clin Cancer Res; 2004 Jan; 10(2):770-6. PubMed ID: 14760100
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of Action of G-Quadruplex-Forming Oligonucleotide Homologous to the Telomere Overhang in Melanoma.
Chhabra G; Wojdyla L; Frakes M; Schrank Z; Leviskas B; Ivancich M; Vinay P; Ganapathy R; Ramirez BE; Puri N
J Invest Dermatol; 2018 Apr; 138(4):903-910. PubMed ID: 29203363
[TBL] [Abstract][Full Text] [Related]
30. A small molecule inhibitor of Pot1 binding to telomeric DNA.
Altschuler SE; Croy JE; Wuttke DS
Biochemistry; 2012 Oct; 51(40):7833-45. PubMed ID: 22978652
[TBL] [Abstract][Full Text] [Related]
31. Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro.
Kelleher C; Kurth I; Lingner J
Mol Cell Biol; 2005 Jan; 25(2):808-18. PubMed ID: 15632080
[TBL] [Abstract][Full Text] [Related]
32. Functional diversity of human protection of telomeres 1 isoforms in telomere protection and cellular senescence.
Yang Q; Zhang R; Horikawa I; Fujita K; Afshar Y; Kokko A; Laiho P; Aaltonen LA; Harris CC
Cancer Res; 2007 Dec; 67(24):11677-86. PubMed ID: 18089797
[TBL] [Abstract][Full Text] [Related]
33. [Telomerase inhibitor, telomestatin, a specific mechanism to interact with telomere structure].
Shin-ya K
Nihon Rinsho; 2004 Jul; 62(7):1277-82. PubMed ID: 15283144
[TBL] [Abstract][Full Text] [Related]
34. Human RTEL1 stabilizes long G-overhangs allowing telomerase-dependent over-extension.
Porreca RM; Glousker G; Awad A; Matilla Fernandez MI; Gibaud A; Naucke C; Cohen SB; Bryan TM; Tzfati Y; Draskovic I; Londoño-Vallejo A
Nucleic Acids Res; 2018 May; 46(9):4533-4545. PubMed ID: 29522136
[TBL] [Abstract][Full Text] [Related]
35. POT1-TPP1 telomere length regulation and disease.
Aramburu T; Plucinsky S; Skordalakes E
Comput Struct Biotechnol J; 2020; 18():1939-1946. PubMed ID: 32774788
[TBL] [Abstract][Full Text] [Related]
36. Germline mutations in Protection of Telomeres 1 in two families with Hodgkin lymphoma.
McMaster ML; Sun C; Landi MT; Savage SA; Rotunno M; Yang XR; Jones K; Vogt A; Hutchinson A; Zhu B; Wang M; Hicks B; Thirunavukarason A; Stewart DR; Koutros S; Goldstein AM; Chanock SJ; Caporaso NE; Tucker MA; Goldin LR; Liu Y
Br J Haematol; 2018 May; 181(3):372-377. PubMed ID: 29693246
[TBL] [Abstract][Full Text] [Related]
37. TIN2 binds TRF1 and TRF2 simultaneously and stabilizes the TRF2 complex on telomeres.
Ye JZ; Donigian JR; van Overbeek M; Loayza D; Luo Y; Krutchinsky AN; Chait BT; de Lange T
J Biol Chem; 2004 Nov; 279(45):47264-71. PubMed ID: 15316005
[TBL] [Abstract][Full Text] [Related]
38. PTOP interacts with POT1 and regulates its localization to telomeres.
Liu D; Safari A; O'Connor MS; Chan DW; Laegeler A; Qin J; Songyang Z
Nat Cell Biol; 2004 Jul; 6(7):673-80. PubMed ID: 15181449
[TBL] [Abstract][Full Text] [Related]
39. The topoisomerase II catalytic inhibitor ICRF-193 preferentially targets telomeres that are capped by TRF2.
Chen L; Zhu X; Zou Y; Xing J; Gilson E; Lu Y; Ye J
Am J Physiol Cell Physiol; 2015 Mar; 308(5):C372-7. PubMed ID: 25518961
[TBL] [Abstract][Full Text] [Related]
40. The telomerase inhibitor telomestatin induces telomere shortening and cell death in Arabidopsis.
Zhang L; Tamura K; Shin-ya K; Takahashi H
Biochim Biophys Acta; 2006 Jan; 1763(1):39-44. PubMed ID: 16473138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
